Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions
The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
The relationship between plaque pathology and disease duration was examined in 15 patients with multiple sclerosis who died early in the course of their illness. Myelin-stained sections revealed that most plaques examined in patients who died during the first month of their illness showed evidence of ongoing myelin destruction accompanied by a loss of oligodendrocytes. Plaques containing large numbers of oligodendrocytes were not observed in these patients, but were relatively common in patients who died more than 1 month after clinical onset. Remyelination affecting more than 10% of the plaque area was observed in 3 of 82 plaques in 5 patients who died within 10 weeks of clinical onset, in 38 of 105 plaques in 5 patients who died 3 to 10 months after clinical onset, and in 19 of 92 plaques in 5 patients who died 18 months or longer after clinical onset. The study provides new evidence that both oligodendrocytes and myelin are destroyed in new lesions, that this activity ceases completely in many lesions within a few weeks, and that remyelination frequently ensues following repopulation of the plaque by oligodendrocytes. The findings suggest that new lesions normally remyelinate unless interrupted by recurrent activity and that remyelinated shadow plaques are the outcome of a single previous episode of focal demyelination.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For cortical grey matter, this now indicates that oligodendrocyte recruitment and remyelination is an early phenomenon in MS lesion formation that occurs in the immediate post-phagocytic phase when foam cells are still abundant in the demyelinated lesions.56-60”
From BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis (2025) · cites this paper as [57]
In the citing paper
“However, despite remyelination being very efficient at the early stages of the disease, this process gradually fails over time [115,116].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [115]
Citations
Cites
Handbook of clinical neurology
(1986) · Journal of Neuroimmunology · doi:10.1016/0165-5728(86)90030-5 · Cited by 1,849
Lantos, P. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.5.496 · Cited by 1,152
Walton, J. N. (1976) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(76)90157-x · Cited by 964
Payne, J. P. (1969) · British Journal of Anaesthesia · doi:10.1093/bja/41.4.356 · Cited by 600
Remyelination in multiple sclerosis
Prineas, J. W., & Connell, F. (1979) · Annals of Neurology · doi:10.1002/ana.410050105 · Cited by 454
Self-citationRemyelination in multiple sclerosis
Piaton, G., Williams, A., Seilhean, D., & Lubetzki, C. (2009) · Progress in Brain Research · doi:10.1016/s0079-6123(09)17530-1 · Cited by 441
ULTRASTRUCTURAL STUDY OF REMYELINATION IN AN EXPERIMENTAL LESION IN ADULT CAT SPINAL CORD
Bunge, M. B., Bunge, R. P., & Ris, H. (1961) · The Journal of Cell Biology · doi:10.1083/jcb.10.1.67 · Cited by 396
Proliferating bipotential glial progenitor cells in adult rat optic nerve
ffrench-Constant, C., & Raff, M. C. (1986) · Nature · doi:10.1038/319499a0 · Cited by 385
Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis
Lassmann, H. (1983) · Schriftenreihe Neurologie / Neurology Series · doi:10.1007/978-3-642-45558-2 · Cited by 296
Pathology of the Nervous System
Krigman, M. R. (1969) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1969.03160150057026 · Cited by 286
Research works printed but not linked: 3
- Schlesinger H, 1909, Zur Frage der akuten multiplen Sklerose und der Enzephalomyelitis disseminata im Kindesalter, Arch Neurol Inst, Wien, 17, 410
- Greenfield JG, 1958, Neuropathology, 441
- Jacob H, 1969, Tissue process in multiple sclerosis and parainfectious and post‐vaccinal encephalomyelitis, Int Arch Allergy Appl Immunol, 36, 22
Cited by
Items 501–571 of 571
The cuprizone model and multiple sclerosis : disparities and similarities
Kipp, M., & Baumgärtner, W. (2011) · RWTH Publications (RWTH Aachen) · Cited by 1
Harnessing Endogenous Stem Cells for Central Nervous System Repair
Lie, D. C., Colamarino, S. A., Song, H., & Gage, F. H. (2005) · Elsevier eBooks · doi:10.1016/b978-012738903-5/50024-2
Genetic and Immunological Regulation of Neuroinflammation
Hedreul, M. T. (2012) · Figshare
Fatiga en esclerosis múltiple: aspectos clínicos, biológicos y radiológicos
Lara, N. T. (2006) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Euphoria in multiple sclerosis: an investigation of constructs and symptons
Duncan, A. L. (2014) · Open University of Cape Town (University of Cape Town) · Cited by 1
Modelling Multiple Sclerosis In Vitro and the Influence of Activated Macrophages
Vereyken, E. J. F., Dijkstra, C. D., & Teunisse, C. E. (2011) · InTech eBooks · doi:10.5772/30525
“Remyelination can be restricted to the lesion edge, but can also extend throughout the lesions which are then called shadow-plaques [Bruck et al., 2003; Prineas et al., 1993; Prineas and Connell, 1979; Raine and Wu, 1993; Lassmann et al., 1997].”
BackgroundThe Role of the Chemokine GRO-1 in the Development of Vertebrate CNS Glial Cells
Miller, R. H., & Robinson, S. (2002) · Elsevier eBooks · doi:10.1016/b978-044451002-0/50020-8
Neuromuscular Characteristics of Multiple Sclerosis Patients
Scott, S. M. (2008) · Stirling Online Research Repository (University of Stirling)
Mechanisms and Patterns of Axonal Loss in Multiple Sclerosis
Mayo, Z., & Jacob, A. (2012) · InTech eBooks · doi:10.5772/35703
Kolappan, M. (2013) · UCL Discovery (University College London)
Putative biomarkers of neuro-restoration in the CNS
Gnanapavan, S. (2013) · UCL Discovery (University College London)
Glial cell reactivity in mouse models reflecting different aspects of Alzheimer's disease
Behrendt, M. G. (2012) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.14767
Magnetic Resonance and Blood-Brain Barrier Dysfunction in Multiple Sclerosis
Rovaris, M., Tortorella, C., Sipe, J. C., & Filippi, M. (1999) · Springer eBooks · doi:10.1007/978-88-470-2143-3_19
Simone, I. L., Tortorella, C., Giannini, P., Trojano, M., & Livrea, P. (1996) · Springer eBooks · doi:10.1007/978-88-470-2205-8_11
Genetic and Immunological Mechanisms Regulating Neuroinflammation
Gillett, A. (2010) · Figshare
Adult neural stem cells in neuroinflammation
Covacu, R. (2008) · Figshare
Amelioration of experimental allergic encephalomyelitis (eae) by phase 2 enzyme inducer
Yunus, M. (2010) · University Library - University of Saskatchewan (University of Saskatchewan)
Lassmann, H. (2003) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Transdermal Histamine in Multiple Sclerosis, Part Two: A Proposed Theoretical
Gillson, G., Wright, J. V., DeLack, E., & Ballasiotes, G. (2000)
Imitola, J., Snyder, E. Y., Khoury, S. J., Khoury, J. B. E., Frenkel, D., Li, J., Sidman, R. L., Walsh, C. A., Raddassi, K., Müeller, F.-J., et al. (2015)
Towards endophenotyping multiple sclerosis
Strijbis, E. M. M. (2014) · Pure Amsterdam UMC
Embryonic stem cell-derived populations retain their tumorigenic potential
Apicella, M. (2009) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3df6rgz
“Although drug therapies can abate the progression of MS, no treatment has reported significant repair of lost myelin (Prineas et al, 1993; Bechmann, 2005).”
BackgroundKassler, S. W. (2006) · doi:10.6083/m4qv3js1 · Cited by 1
Quels espoirs de remyélinisation dans la sclérose en plaques
Rogister, B., Wislet‐Gendebien, S., & Belachew, S. M. (2002) · ORBi (University of Liège)
Belachew, S. M. (2005) · ORBi (University of Liège)
Characterising the Adult Human Oligodendrocyte Progenitor
Scolding, N. J., Shaw, C. E., & Compston, A. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5949-8_24
(Stem) Cell Based Therapy for Neurological Disorders
Einstein, O., & Ben‐Hur, T. (2010) · Royal Society of Chemistry eBooks · doi:10.1039/9781849732246-00203
Le phénomène de remyélinisation dans la sclérose en plaques
Lubetzki, C. (2003) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)34000-2 · Cited by 1
SVEUČILIŠTE U ZAGREBU MEDICINSKI FAKULTET
Krajcar, N. (2014)
Pathologie und Pathophysiologie
Stadelmann, C., & Brück, W. (2015) · Elsevier eBooks · doi:10.1016/b978-3-437-22083-8.00004-3 · Cited by 1
Optical coherence tomography and electrophysiology of the visual pathway
Klistorner, A. I., Fraser, C. L., Yiannikas, C., & Graham, S. L. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139649506.008
Brex, P. (2001) · UCL Discovery (University College London)
Sclérose en plaques : les nouvelles approches physiopathologiques
Zéphir, H. (2019) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2019.02.011
Role of Extracellular Vesicles on Immune Regulation in an Animal Model of Multiple Sclerosis
Willis, C. M. (2019) · OpenCommons - UConn (University of Connecticut)
Anatomie pathologique de la sclérose en plaques et des maladies apparentées
Seilhean, D., & Merkler, D. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-71420-7.00004-5
Demyelinating conditions regulated by ROS pathways outside and inside the brain
Carlström, K. E. (2020) · Figshare · Cited by 1
Imaging of Demyelination, Repair and Remyelination in Multiple Sclerosis
Mallik, S. (2020) · UCL Discovery (University College London)
Early Retinal Changes Following Paediatric Optic Neuritis
Wilbur, C. (2018) · TSpace (University of Toronto)
Thorpe, J. W. (1999) · UCL Discovery (University College London)
MRI quantification of multiple sclerosis pathology
Ouellette, R. (2021) · Figshare
Strategies to Promote Neuroprotection and Repair in Multiple Sclerosis
Ben‐Hur, T. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6068-0.00021-8
(2021) · Elsevier eBooks · doi:10.1016/b978-3-437-22085-2.00028-8
(2006) · Elsevier eBooks · doi:10.1016/b978-0-443-07271-0.50022-7
Chan, J. W. (2014) · Springer eBooks · doi:10.1007/978-1-4614-0691-4_1
Chan, J. W. (2008) · Springer eBooks · doi:10.1007/978-0-387-68979-1_1
On the effect of remyelination in a mathematical model of multiple sclerosis
Bazlyankov, G., & Ivanov, T. (2023) · BIOMATH · doi:10.55630/j.biomath.2023.09.267
“Such a scenario proves to be too unrealistic in many cases, however, since remyelination is regularly examined to be a concomitant process with multiple sclerosis in many patients [19].”
BackgroundMicroglial glutathione and glutamate: regulation mechanisms
Fry, V. A. H. (2009) · UCL Discovery (University College London) · Cited by 1
Gasqué-Rubio, R., Cubas-Núñez, L., Castillo-Villalba, J., Casas-Hidalgo, L., Forés-Toribio, L., Carratalà‐Boscà, S., Tortosa-Carreres, J., Alcalà-Vicente, C., Quintanilla‐Bordás, C., Górriz, D., et al. (2026) · OMICS A Journal of Integrative Biology · doi:10.1177/15578100261479076
Physiopathologie de la sclérose en plaques
Dubessy, A., & Stankoff, B. (2025) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(25)46803-1
Moghrabi, H. A., Audi, Z. F., Ayache, M., Chmaisse, H. N., Harati, H., & Estephan, E. (2025) · International Conference on Advances in Biomedical Engineering (ICABME) · doi:10.1109/icabme66883.2025.11211618
Oligodendrocytes as active modulators of neuroinflammation
Janssen, K., & Beyer, C. (2014) · RWTH Publications (RWTH Aachen)
Lohrberg, M., Winkler, A., Franz, J., van der Meer, F., Ruhwedel, T., Sirmpilatze, N., Dadarwal, R., Löber-Handwerker, R., Esser, D. S., Wiegand, K., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13488672
Fisiopatologia della sclerosi multipla
Dubessy, A., & Stankoff, B. (2026) · EMC - Neurologia · doi:10.1016/s1634-7072(25)51364-8
Damsbo, K., Reyahi, A., Nik, A. M., Oubounyt, M., Weber, A., Hyrlov, K. H., Kingo, C., Foged, M. L., Waede, M., Baumbach, J., et al. (2026) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2026.578896
Étude neurophysiologique de l’excitabilité corticale et du tremblement dans la sclérose en plaques
Ayache, S. S. (2014) · theses.fr (ABES) · doi:10.70675/5cf6322bz393ez4ff1z843fz9c7ba8d4e8b4
Sanson, C. (2017) · theses.fr (ABES) · doi:10.70675/205f3741zaac1z422eza6aeza2902010260f · Cited by 1
Thétiot, M. (2018) · theses.fr (ABES) · doi:10.70675/4fd006d4z6c0ez4fe8zbcd0z0df8b8ef8d85
Nonlinear optical microscopy of nervous tissue : lipid and metabolism imaging
Asadipour, B. (2023) · theses.fr (ABES) · doi:10.70675/a6df7cc5z7b3cz4971zb3edzfa969cc63866
Microenvironmental Regulation of Central Nervous System Myelination and Remyelination
Wang, Y., Tan, L., Lao, L., Huang, X., Zhang, S., & Sun, H. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin43257 · Cited by 1
Myelin Repair as a Neuroprotective Strategy for Multiple Sclerosis: From Bench to Bedside
Battah, T., Mastorodemos, V., Struecker, E., Mitsikostas, D. D., & Papadopoulos, D. (2026) · Medicina · doi:10.3390/medicina62061183
Kazanis, I., Silva, M. E., de la Fuente, A. G., de Castro, F., & Rivera, F. J. (2026) · Acta Physiologica · doi:10.1111/apha.70285
Immune Modulation and Repair Following Neural Stem Cell Transplantation
Ben‐Hur, T., Pluchino, S., & Martino, G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2218-1_7
(1997) · doi:10.1002/(sici)1097-4547(19971015)50:2<215::aid-jnr10>3.0.co;2-7
Metadata
- Authors
- Prineas, J. W., Barnard, R. O., Kwon, E. E., Sharer, L. R., & Cho, E. ‐.
- Affiliations
- East Orange VA Medical Center (US)
- Rutgers New Jersey Medical School (US)
- Corresponding author
- Prineas, J. W.
- ORCID
- Prineas, J. W.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1993-02
- Volume
- 33
- Issue
- 2
- Pages
- 137-151
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2024751716
- Cited by
- 574
- References
- 46
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 7 · 2023: 9 · 2022: 10 · 2021: 13 · 2020: 14 · 2019: 19 · 2018: 14 · 2017: 12 · 2016: 10 · 2015: 14 · 2014: 18 · 2013: 13 · 2012: 16
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- multiple sclerosis, remyelination, demyelination, oligodendrocytes, myelin destruction, disease duration, early-onset multiple sclerosis
- MeSH terms
- Adolescent, Adult, Aged, Axons, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Myelin Sheath, Nerve Regeneration, Oligodendroglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.